Cargando…

Bioactivities of EF24, a Novel Curcumin Analog: A Review

Curcumin is an attractive agent due to its multiple bioactivities. However, the low oral bioavailability and efficacy profile hinders its clinical application. To improve the bioavailability, many analogs of curcumin have been developed, among which EF24 is an excellent representative. EF24 has enha...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yonghan, Li, Wen, Hu, Guangrong, Sun, Hui, Kong, Qingpeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297553/ https://www.ncbi.nlm.nih.gov/pubmed/30619754 http://dx.doi.org/10.3389/fonc.2018.00614

Ejemplares similares

The curcumin analog EF24 is a novel senolytic agent
por: Li, Wen, et al.
Publicado: (2019)

In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog
por: Liu, Haitao, et al.
Publicado: (2012)

A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies
por: Bisht, Savita, et al.
Publicado: (2016)

Autophagy and Apoptosis in Hepatocellular Carcinoma Induced by EF25-(GSH)(2): A Novel Curcumin Analog
por: Zhou, Tao, et al.
Publicado: (2014)

The Curcumin Analog EF24 Targets NF-κB and miRNA-21, and Has Potent Anticancer Activity In Vitro and In Vivo
por: Yang, Chuan He, et al.
Publicado: (2013)

Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer
por: Xie, Xuemeng, et al.
Publicado: (2017)

EF-24, a Curcumin Analog, Inhibits Cancer Cell Invasion in Human Nasopharyngeal Carcinoma through Transcriptional Suppression of Matrix Metalloproteinase-9 Gene Expression
por: Su, Shih-Chi, et al.
Publicado: (2023)

Effects of Curcumin Analogues DMC and EF24 in Combination with the Cytokine TRAIL against Kidney Cancer
por: Ibáñez Gaspar, Verónica, et al.
Publicado: (2021)

Inhibition of HIV-1 by curcumin A, a novel curcumin analog
por: Kumari, Namita, et al.
Publicado: (2015)

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
por: Khan, Sajid, et al.
Publicado: (2020)

Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines
por: Bertazza, Loris, et al.
Publicado: (2019)

Bioactivity Evaluation of a Novel Formulated Curcumin
por: Liao, Se-Chun, et al.
Publicado: (2019)

Application of a Novel Curcumin Analog in the Management of Diabetic Cardiomyopathy
por: Ren, Jun, et al.
Publicado: (2014)

The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections
por: Abbas, Wasim, et al.
Publicado: (2015)

Natural Sources and Bioactivities of 2,4-Di-Tert-Butylphenol and Its Analogs
por: Zhao, Fuqiang, et al.
Publicado: (2020)

Resveratrol analog, triacetylresveratrol, a potential immunomodulator of lung adenocarcinoma immunotherapy combination therapies
por: He, Jian, et al.
Publicado: (2023)

Synthesis and Evaluation of a Series of Novel Asymmetrical Curcumin Analogs for the Treatment of Inflammation
por: Zhang, Yali, et al.
Publicado: (2014)

Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer’s Disease
por: Gagliardi, Stella, et al.
Publicado: (2018)

Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs
por: Pignanelli, Christopher, et al.
Publicado: (2017)

Anticancer Properties of Curcumin Against Colorectal Cancer: A Review
por: Ojo, Oluwafemi Adeleke, et al.
Publicado: (2022)

Induced Resistance Mechanism of Novel Curcumin Analogs Bearing a Quinazoline Moiety to Plant Virus
por: Yin, Limin, et al.
Publicado: (2018)

Curcumin as an Adjuvant to Cancer Immunotherapy
por: Paul, Silpita, et al.
Publicado: (2021)

A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma
por: Wang, Hao, et al.
Publicado: (2021)

Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer
por: Bhatt, Akshita B., et al.
Publicado: (2019)

Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury
por: Zhang, Yali, et al.
Publicado: (2015)

The Novel Curcumin Derivative 1g Induces Mitochondrial and ER-Stress-Dependent Apoptosis in Colon Cancer Cells by Induction of ROS Production
por: Wang, Hao, et al.
Publicado: (2021)

In Vivo Efficacy and Toxicity of Curcumin Nanoparticles in Breast Cancer Treatment: A Systematic Review
por: Ombredane, Alicia S., et al.
Publicado: (2021)

Curcumin as a Potential Therapeutic Agent in Certain Cancer Types
por: Vadukoot, Anish K, et al.
Publicado: (2022)

Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs
por: Rath, Kellie S, et al.
Publicado: (2013)

Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity
por: Jha, Narendra Nath, et al.
Publicado: (2016)

Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs
por: MUJTABA, TASKEEN, et al.
Publicado: (2012)

The progress of protein synthesis factors eIFs, eEFs and eRFs in inflammatory bowel disease and colorectal cancer pathogenesis
por: Huang, Conggai, et al.
Publicado: (2022)

Discovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcumin
por: Zhang, Yali, et al.
Publicado: (2014)

Rpl24(Bst) mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K
por: Knight, John RP, et al.
Publicado: (2021)

Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma
por: Lu, Ko-Hsiu, et al.
Publicado: (2023)

Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents
por: Zhang, Yali, et al.
Publicado: (2014)

GBAS Regulates the Proliferation and Metastasis of Ovarian Cancer Cells by Combining with eEF1A1
por: Ning, Xin, et al.
Publicado: (2022)

Anti-Lung Cancer Activity of the Curcumin Analog JZ534 In Vitro
por: Wu, Jianzhang, et al.
Publicado: (2015)

Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors
por: Landais, Igor, et al.
Publicado: (2009)

Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
por: Guo, Kaibo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qc0dbq0rmnbtajmnav69p2m21j